Latest posts tagged with #prostateCancer on Bluesky
Could a tool combining genetics with family history improve #ProstateCancer screening?
An international team including multiple Prostate Cancer UK funded researchers detail the findings of the ProGRESS study in @natcancer.nature.com.
Grab a ☕ and read: www.nature.com/articles/s43...
SPECT scans can provide early response information in prostate cancer patients treated with lutetium-177 (Lu-177) prostate-specific membrane antigen-617 (Lu-177 PSMA-617) #radiology #prostatecancer #SPECT
A recent study published in the journal Cancer explores whether #ProstateCancer drugs increase bleeding or clotting risks when combined with blood thinners🩸
HealthDay covers the findings: https://ow.ly/bEjs50Yv2HJ
#TrendingResearchTuesday
American Cancer Society
A new #ProstateCancer drug is showing really promising early results 🧪🙂 In trials, it helped shrink #tumours in some patients and caused only mild side effects, improving treatment options in the future. This kind of breakthrough could give people more time and better quality of life ❤️
A rationale for #SBRT to #Oligomets in #PSMA+BCR is “delay #ADT”
But this presupposes #PSMA+#BCR requires ADT/ARPI…
What if that’s not the case & most PSMA+BCR #ProstateCancer was indolent?
Thats what a study @theNCI shows @asco #Gu26
shorturl.at/IyBBT
Four studies presented at the European Association of Urology 2026 congress in London are reshaping how we think about prostate cancer screening — and MRI is at the center of it all #ProstateCancer #MRI #Urology #Radiology #EAU2026 #CancerScreening #Oncology buff.ly/kkZp09U
2026 PSMA & Beyond Conference | March 26–27, 2026 Luskin Conference Center, Los Angeles. Two-day educational meeting bringing together #ProstateCancer imaging, therapy, and research experts. Co-sponsors UCLA, @ucsanfrancisco.bsky.social @pcf-science.bsky.social
radiology.ucsf.edu/events/2026-...
The March edition of Research News is here! Learn about:
🆕 Our new Black Health Equity strategy
💰 New funding opportunities
💙 How our research makes a real impact for men with #ProstateCancer
📰 Recent prostate cancer research articles
Read here: buff.ly/8Sd6vxh
A #study comparing outcomes after #prostatecancer and #breastcancer #screening has shown that both are effective at #diagnosing cases, reducing deaths, and avoiding unnecessary harm.
The #OncoAlertColloquium 2026 GU Malignancies🚨 #EAU26
Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer
REGISTER HERE TO WATCH👉 vimeo.com/1160841460?s...
Four practice-changing trials are reshaping prostate cancer care
✅️ AMPLITUDE
✅️STOPCaP
✅️ ENZARAD
✅️ PR21
Day 2 of the 19th Annual NY GU Cancers Congress is in full swing! Check out onclive.com for all of our coverage of the meeting #oncology #kcsm #RCC #prostatecancer
Great discussion this morning at #EAU26 on health literacy and shared decision making for vulnerable patients with prostate cancer.
Thanks to everyone that joined the session! 💙
#CLEARPC #EU4Health #ProstateCancer #HealthLiteracy
Encouraging news in prostate cancer research: pairing next-generation immunotherapy with standard hormone therapy before surgery may help overcome long-standing treatment barriers.
#ProstateCancer #Immunotherapy #CancerResearch #Oncology #TCSC
cancerletter.com/the-cancer-l...
PSA50 outcomes with lutetium Lu-177 vipivotide tetraxetan did not differ by race in patients with mCRPC, according to data from retrospective cohort study presented during @ascocancer.bsky.social #GU26 #oncology #pcsm #prostatecancer
Read more here: www.onclive.com/view/racial-...
NCHR President Diana Zuckerman told reporters this panel should include more diversity of opinion than has been seen recently.
Cancer patients deserve rigorous, transparent reviews with solid evidence.
#FDA #CancerResearch #BreastCancer #ProstateCancer
www.biospace.com/fda/two-astr...
Thank you to Maha H. Hussain, MD, FACP, FASCO, of @nufeinbergmss.bsky.social for presenting on treatment intensification in mHSPC! Stay tuned to onclive.com for all of our coverage of the 19th Annual NY GU Cancers Congress! #oncology #pcsm #ProstateCancer
PSMA PET/CT #imaging uses a molecule that highlights aggressive #ProstateCancer cells as bright spots, helping distinguish cancers that require treatment from low-risk cases to prevent #overdiagnosis.
#PSMAPETCT #EAU26
March Issue: Lymph Node Invasion Prediction in #ProstateCancer : A Comparative Machine-Learning Study
https://rdcu.be/e70D3
Dr @alison-tree.bsky.social led the TRAP trial at The Royal Marsden, exploring targeted SBRT, a precise radiotherapy, for men with advanced #ProstateCancer.
The trial looked at whether SBRT could delay chemotherapy and maintain quality of life.
📙 Read more: prostatecanceruk.org/research/res...
New #ProstateCancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study. www.thelancet.com/journals/lan...
Podcast: Current Insights and Emerging Trends in #MolecularImaging and #Theranostics for #ProstateCancer
www.diagnosticimaging.com/view/reading...
#radiology #RadRes
Dr Jason Efsthathiou, presents PEACE-3 data: Adding Radium-223 to enzalutamide prolongs rPFS (19.4 vs 16.4 mo, HR 0.69) in #mCRPC with bone metastases. Research from Dr Enrique Gallardo.
Read the review and watch the full interview at: ➡️ https://bit.ly/4rNUPUK
#MedEd #OncTwitter #ProstateCancer
Dr. Ernie Kninjing on survival outcomes among patients with #prostatecancer , from Georgia College and State University, Georgia.
Quality of Care and Survival Outcomes Among Patients With Clinically Localized Prostate Cancer in Nigeria...
pmc.ncbi.nlm.nih.gov/articles/PMC...
📍 The CLEAR-PC project will be at #EAU26 in London this weekend!
Join us on Saturday (14 March) for two sessions on prostate cancer, health literacy, and shared decision-making.
Looking forward to connecting at the congress.
#CLEARPC #ProstateCancer #HealthLiteracy #EU4Health
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TRRj7w !
#Oncology #SocialListening #LucidQuest
Dr. Scott Tyldesley of UBC reports on 15-year ASCENDE-RT data: Brachytherapy boost halves PC-specific mortality (8.6% vs 16.4%, P=.007) but shows no OS benefit.
Read more here: ➡️ https://bit.ly/3OGoIaH
#pcsm #prostatecancer #ASCOGU26 #GU26
Dr. Faruk Mohammed on #prostatecancer early detection, from Ahmadu Bello University Teaching Hospital, Nigeria.
An intervention mapping approach to the development and evaluation of a community-based prostate cancer early detection...
pmc.ncbi.nlm.nih.gov/articles/PMC...
Alicia Morgans, MD, MPH, of @danafarber.bsky.social discusses data from a real-world analysis of androgen pathway receptor triplet regimens in mHSPC that were presented during the 2026 Genitourinary Cancers Symposium. #GU26 #prostatecancer #pcsm
🔷 Findings highlight how advanced imaging may refine prognosis and guide more personalized treatment strategies in prostate cancer.
🔗 Read more: bit.ly/ONCOnews-11M...
#ONCOnews #OncoAlert #OncEd #ProstateCancer #PSMAPET #Oncology #CancerResearch #CancerImaging #PrecisionMedicine #Urology #Cancer
📣 New Podcast! "S2E140- Barbie does what? Celebrity phobias and more" on @Spreaker #barbie #prostatecancer
